Orlistat as a fatty acid synthase inhibitor blocks cell survival mechanism via activating PTEN, which controls PI3K/AKT/MAPK axis in PC3 prostate cancer cells

Saved in:
Bibliographic Details
Published inJournal of biotechnology Vol. 256; p. S31
Main Authors Aras, Sahra, Ozdemir, Beril Su, Arisan, Elif Damla, Rencuzogullari, Ozge, Ozfiliz, Pelin, Yerlikaya, Pinar Obakan, Gurkan, Ajda Coker, Unsal, Narcin Palavan
Format Journal Article
LanguageEnglish
Published Elsevier B.V 30.08.2017
Online AccessGet full text

Cover

More Information
ISSN:0168-1656
1873-4863
DOI:10.1016/j.jbiotec.2017.06.654